摘要
目的 分析研讨舒芬太尼复合丙泊酚麻醉在腹腔镜子宫肌瘤剔除术中的应用效果。方法 对2020年6月-2021年6月间在我院接受腹腔镜子宫肌瘤剔除术治疗的74例患者，进行随机抽取，各抽取37例，设为研究和对照两组，采用丙泊酚麻醉的为对照组，实施舒芬太尼复合丙泊酚麻醉的为研究组，比较两组患者的麻醉效果、麻醉指标、不良反应发生率以及疼痛程度。结果 研究组麻醉总优良率97.30%比对照组75.68%高（P＜0.05）。研究组病人的苏醒时间、自主呼吸恢复时长、睁眼时间、定向力恢复时长以及拔管时间等各项麻醉指标均优于对照组（P＜0.05）。研究组的不良反应总发生率10.81%比对照组32.43%低（P＜0.05）。结论 舒芬太尼复合丙泊酚麻醉在腹腔镜子宫肌瘤剔除术中的应用效果显著，能明显改善病人各类麻醉指标，降低恶心、腹胀、呕吐以及尿潴留等不良反应的发生，提高麻醉安全性，适合临床应用。
关键词： 舒芬太尼；丙泊酚；腹腔镜；子宫肌瘤剔除术；应用效果
Abstract
Objective To analyze the effect of sufentanil combined with propofol anesthesia in laparoscopic myomectomy. Methods 74 patients who underwent laparoscopic myomectomy in our hospital from June 2020 to June 2021 were randomly selected. 37 patients were selected from each group and set as the study and control groups. The patients who were anesthetized with propofol were set as the control group, and the patients who were anesthetized with sufentanil combined with propofol were set as the study group. The anesthetic effect, anesthetic index, incidence of adverse reactions and degree of pain were compared between the two groups. Results the total excellent and good rate of anesthesia in the study group was 97.30% higher than 75.68% in the control group (P < 0.05). The anesthetic indexes of the study group were better than those of the control group (P. The total incidence of adverse reactions in the study group was 10.81% lower than 32.43% in the control group (P < 0.05). Conclusion sufentanil combined with propofol anesthesia has a significant effect in laparoscopic myomectomy. It can significantly improve various anesthetic indexes, reduce the occurrence of adverse reactions such as nausea, abdominal distension, vomiting and urinary retention, and improve the safety of anesthesia. It is suitable for clinical application.
Key words： Sufentanil; Propofol; Laparoscope; Myomectomy of uterus; Application effect
参考文献 References
[1] 魏立国,张英立,宋雯.异丙酚复合舒芬太尼麻醉对腹腔镜下子宫肌瘤剜除术患者的麻醉效果及对患者内分泌激素及血流动力学的影响[J].中国妇幼保健,2019,34(22):5131-5134.
[2] 沈寿祥.七氟醚和丙泊酚对行腹腔镜子宫肌瘤剔除术患者炎症因子及应激反应的影响[J].中国实验诊断学,2021,25(1):57-60.
[3] 胡喆.丙泊酚对腹腔镜下子宫肌瘤剔除术患者的麻醉效果及对缩血管因子水平的影响[J].医学临床研究,2019,36(9):1706-1708.
[4] 洪波,易洪章,方天明．舒芬太尼联合异丙酚对腹腔镜下子宫肌瘤剔除术患者的应激反应及胃肠动力的影响[J]．医学临床研究,2019,036(004):742-744.
[5] 李登平,王振,冯东.舒芬太尼复合丙泊酚麻醉在子宫肌瘤腹腔镜术中的应用效果及安全性分析[J].解放军预防医学杂志,2019,37(08):159-160+162.
[6] 夏树红,刘荣,桂新星,等.舒芬太尼联合丙泊酚麻醉对子宫肌瘤切除术后患者血流动力学、应激反应的影响[J].腹腔镜外科杂志,2019,24(12):952-956.
[7] 徐国勇,周利,孙昊天,等.宫腔镜子宫肌瘤切除术中应用羟考酮复合丙泊酚的麻醉效果[J].中国计划生育学杂志,2020,28(06):827-830.
[8] 黄娟.不同剂量右美托咪定麻醉在子宫肌瘤腹腔镜手术中的应用分析[J].中国肿瘤临床与康复,2021,28(5):537-539.
[9] 赵静,蒋延安,宁莎莎.地佐辛复合舒芬太尼用于腹腔镜子宫肌瘤剔除术术后镇痛的有效性和安全性[J].山西医药杂志,2019,48(07):818-820.
[10] 俞瑾,宋云,刘春,等.丙泊酚复合小剂量舒芬太尼用于宫腔镜诊治术麻醉的半数有效剂量[J].中国药物依赖性杂志,2020,29(04):305-309.
[11] 许芾,岳洋,陈彪,等.七氟醚联合瑞芬太尼麻醉对腹腔镜下子宫肌瘤切除术病人应激反应及血流动力学的影响[J].蚌埠医学院学报,2020,45(08):1008-1012.
[12] 陈培,刘兰,陈敏敏,等.罗哌卡因腹横肌平面阻滞对腹腔镜子宫肌瘤剔除术患者镇痛效果及应激反应的影响[J].中国内镜杂志, 2021, 27(4):31-37.
[13] 廖海明.腹腔镜子宫肌瘤切除术术后行舒芬太尼靶控镇痛的效果及对患者应激反应、免疫功能的影响[J].医学临床研究,2020,37(5):708-711.
[14] 李敬业,徐志燕,刘炯峰,等.瑞芬太尼复合丙泊酚麻醉对子宫肌瘤剔除术患者血流动力学指标的影响[J].中国药物与临床,2021,21(3): 424-425.
[15] 艾金莲,肖金辉,刘荣,等.七氟醚联合瑞芬太尼麻醉对腹腔镜下子宫肌瘤切除术患者应激反应及血流动力学的影响[J].中国医药导报,2019,16(31):103-106.